A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension

Completed · Phase 3

Conditions studied: Open-Angle Glaucoma, Ocular Hypertension

In brief

The primary objective of this study is to compare the safety and efficacy of Brimonidine Tartrate Ophthalmic Solution, 0.15% in patients with open-angle glaucoma or ocular hypertension.

Key facts

Study ID

NCT00061529

Run by

Alcon Research

Starts

2003-01-01

Expected to finish

2004-07-01

Last updated by the study team

2008-08-05

Who can join

Age: 0 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Alcon Call Center — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.